The Ministry of Food and Drug Safety announced on the 31st that it has approved the rare drug "Voxzogo" for treating ...

Korean scientists discover a groundbreaking method to transform ordinary fibroblasts into mature cardiomyocytes SEOUL, South Korea, Dec. 26, 2024 ...

Tyra Biosciences' shares have dropped sharply after interim data from TYRA-300 showed a superior but not exceptional adverse ...

CEO Emil D. Kakkis sold 11,727 shares of the stock in a transaction dated Monday, December 30th. The stock was sold at an ...

Inc. (NASDAQ:ETNB – Get Free Report) has been given a consensus rating of “Moderate Buy” by the seven research firms that are currently covering the firm, Marketbeat.com reports. Two equities research ...

The Inducement Grant has been granted pursuant to the Company's 2023 Inducement Plan (the "Plan”). The Inducement Grant was ...

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes of the drug, ...

Erdafitinib is under clinical development by Johnson & Johnson and currently in Phase I for Lung Adenocarcinoma.

Find earnings, economic, stock splits and IPO calendars to track upcoming financial events from Yahoo Finance.

We recently published a list of the 12 Best Biotech Penny Stocks To Invest In Now. In this article, we are going to take a ...

Endothelial cells are also likely to participate in activation, both by production of cellular fibronectin and via conversion of transforming growth factor (TGF)-beta from the latent to active ...